Contractor
ACCORD BIOPHARMA, INC.
DURHAM, NC
- UEI
- M3PMHL5VML74
- Parent UEI
- M3PMHL5VML74
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$19,420,7001
Awards
3
Agencies served
2
Active from Dec 6, 2022 to Sep 8, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79723D0039 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Dec 6, 2022 | — |
| 36E79725D0014 NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jan 23, 2025 | — |
| 75A50325C00002 NOVATION AND CHANGE-OF-NAME AGREEMENT | Department of Health and Human Services | CA | Mar 6, 2026 | $19,420,700 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier M3PMHL5VML74, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.